Company · CIK 0001420030 · SIC 2834 — Pharmaceutical Preparations
Targeted Medical Pharma, Inc. · TRGM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2016 AForm 4 → | Mar 8, 6:09 am EST | Thomas Richard WenkartDirector, 10% Owner | 200,000 | $0.05 | $10,000 | 200,000 | — | plan? |
| Mar 4, 2016 AForm 4 → | Mar 7, 5:04 pm EST | Kerry Neil WeemsDirector | 200,000 | $0.05 | $10,000 | 225,000 | — | plan? |
| Mar 4, 2016 AForm 4 → | Mar 7, 5:00 pm EST | David Samuel SilverChief Medical Officer, Director | 575,000 | $0.05 | $28,750 | 575,000 | — | plan? |
| Mar 4, 2016 AForm 4 → | Mar 7, 4:58 pm EST | Kim GiffoniChief Executive Officer, Director, 10% Owner | 547,500 | $0.05 | $27,375 | 751,095 | — | plan? |
| Mar 4, 2016 AForm 4 → | Mar 7, 4:56 pm EST | Maurice J DewaldDirector | 200,000 | $0.05 | $10,000 | 254,000 | — | plan? |
| Mar 4, 2016 AForm 4 → | Mar 7, 4:15 pm EST | William B HorneChief Financial Officer | 342,500 | $0.05 | $17,125 | 674,038 | — | plan? |
| Dec 31, 2015 AForm 4 → | Feb 4, 2016, 11:15 am EST | Thomas Richard WenkartDirector, 10% Owner | 44,058 | $0.30 | $13,217 | 2,107,664 | — | plan? late |
| Nov 24, 2015 SForm 4 → | Nov 24, 4:42 pm EST | Kim Giffoni +2Chief Executive Officer, Director, 10% Owner | 8,580 | $0.015 | $129 | 2,646,668 | −0.32% | plan? |
| Sep 11, 2015 AForm 4 → | Sep 15, 3:27 pm EDT | William B HorneChief Financial Officer | 65,769 | $0.20 | $13,154 | 331,538 | — | plan? |
| Sep 11, 2015 AForm 4 → | Sep 15, 3:23 pm EDT | Kim GiffoniChief Executive Officer, Director, 10% Owner | 68,077 | $0.20 | $13,615 | 212,175 | — | plan? |
| Jun 30, 2015 AForm 4 → | Aug 14, 4:50 pm EDT | Thomas Richard WenkartDirector, 10% Owner | 40,183 | $0.30 | $12,055 | 2,063,606 | — | plan? late |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:18 pm EDT | William B HorneChief Financial Officer | 200,000 | $0.08 | $16,000 | 265,769 | — | plan? |
| May 20, 2015 AForm 4 → | May 26, 6:37 pm EDT | William B HorneChief Financial Officer | 65,769 | $0.20 | $13,154 | 65,769 | — | plan? late |
| May 20, 2015 AForm 4 → | May 26, 6:35 pm EDT | Kim GiffoniChief Financial Officer, Director, 10% Owner | 68,077 | $0.20 | $13,615 | 144,098 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2016 AForm 4 → | Mar 8, 6:09 am EST | Thomas Richard WenkartDirector, 10% Owner | 100,000 | — | — | 100,000 | — | |
| Mar 4, 2016 AForm 4 → | Mar 7, 5:04 pm EST | Kerry Neil WeemsDirector | 100,000 | — | — | 100,000 | — | |
| Mar 4, 2016 AForm 4 → | Mar 7, 4:58 pm EST | Kim GiffoniChief Executive Officer, Director, 10% Owner | 300,000 | — | — | 300,000 | — | |
| Mar 4, 2016 AForm 4 → | Mar 7, 4:56 pm EST | Maurice J DewaldDirector | 100,000 | — | — | 250,000 | — | |
| Mar 4, 2016 AForm 4 → | Mar 7, 4:15 pm EST | William B HorneChief Financial Officer | 200,000 | — | — | 550,000 | — | |
| Jun 17, 2015 AForm 4 → | Jun 19, 3:18 pm EDT | William B HorneChief Financial Officer | 200,000 | — | — | 350,000 | — | |
| Jan 13, 2015 PForm 4 → | Feb 11, 3:14 pm EST | Thomas Richard WenkartDirector, 10% Owner | 2,166,666 | — | — | 2,166,666 | — | late |
| Mar 20, 2010 AJForm 4 → | Mar 7, 2016, 5:00 pm EST | David Samuel SilverChief Medical Officer, Director | 977,469 | — | — | 1,225,077 | — | late |